vimarsana.com

Page 33 - தேசிய ஆர்கநைஸேஶந் க்கு ரேர் கோளாறுகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Liz Uy expecting second child with husband Raymond Racaza

Liz Uy expecting second child with husband Raymond Racaza
inquirer.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from inquirer.net Daily Mail and Mail on Sunday newspapers.

Thyroid Eye Disease (Graves Ophthalmology) Treatments

Everyday Health If you’ve been diagnosed with a thyroid disease, such as Graves’, your doctor may have told you about the complications that can arise in the future. One of them is thyroid eye disease, commonly referred to as Graves’ ophthalmopathy. Thyroid eye disease occurs in about 1 in every 6,250 women and 1 in 34,500 men, according to the National Organization for Rare Disorders. In thyroid eye disease, a person’s immune system attacks the muscles, fat, and other tissues around and behind the eye, resulting in inflammation, scarring, swelling, and more. This inflammation and swelling causes symptoms such as bulging eyes, retracted eyelids, and chronic dry eye, says Ilya Leyngold, MD, an ocular plastic surgeon at Duke Eye Center in Durham, North Carolina.

Zolgensma, rare gene replacement therapy used to treat toddlers with SMA, coming to Alberta

  EDMONTON The Pfizer and Moderna COVID-19 vaccines aren t the only landmark approvals Health Canada has been working on recently.  Zolgensma maker Novartis Pharmaceuticals announced Wednesday its gene therapy used to treat toddlers with spinal muscular atrophy (SMA) had been approved by the federal department. About one in 10,000 Canadian babies are born with a type of SMA each year, according to the National Organization for Rare Disorders. The genetic neuromuscular disease is caused by a defective or missing SMN1 gene, which results in a loss of muscle function. The young patients diagnosed with SMA often have trouble breathing, swallowing and crawling.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.